BlackRock »

Benitec Biopharma shares owned by BlackRock

Quarter-by-quarter ownership of Benitec Biopharma (BNTC) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Benitec Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Benitec Biopharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Benitec Biopharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-06-30 $196k 28k 6.99

More positions owned by BlackRock

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
UnitedHealth (UNH)
Ishares Tr Core S&p500 Etf (IVV)
Exxon Mobil Corporation (XOM)

View all positions for BlackRock

Top funds holding Benitec Biopharma

Suvretta Capital Management
Henderson Group
Nantahala Capital Management
Franklin Resources
Schonfeld Strategic Advisors
Vanguard Group
Adage Capital Partners GP
Geode Capital Management
Simplify Asset Management
BlackRock
Morgan Stanley
GAMMA Investing
Tower Research Capital
UBS Group
Rhumbline Advisers

View all funds holding Benitec Biopharma